Pioneers in boldly advancing science
Frontier Medicines is a clinical-stage precision medicine company pioneering covalent small-molecule drug discovery against previously undruggable targets. Its Frontier Platform combines chemoproteomics with machine learning to identify novel covalent binding sites across the proteome. The company has advanced multiple oncology development candidates and holds partnerships with major biopharma companies including AbbVie.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJun 2024
Feb 2024
Jul 2021
Oct 2019
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
